MedBen Benefits Advisory Conference Highlights Key Industry Trends

Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants

Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...

As Health Care Costs Climb, Stability Matters More Than Ever

Dec 2, 2025 | Alternative Reimbursement Strategies, Cost management, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, Health care costs, High-cost claims, MedBen Analytics, MedBen Rx, MedBen WellLiving, Rx Costs, Self-funding, Survey

As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....